Correlation Between Bristol-Myers Squibb and FactSet Research
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and FactSet Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and FactSet Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and FactSet Research Systems, you can compare the effects of market volatilities on Bristol-Myers Squibb and FactSet Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of FactSet Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and FactSet Research.
Diversification Opportunities for Bristol-Myers Squibb and FactSet Research
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bristol-Myers and FactSet is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and FactSet Research Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FactSet Research Systems and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with FactSet Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FactSet Research Systems has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and FactSet Research go up and down completely randomly.
Pair Corralation between Bristol-Myers Squibb and FactSet Research
Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 2.84 times more return on investment than FactSet Research. However, Bristol-Myers Squibb is 2.84 times more volatile than FactSet Research Systems. It trades about 0.12 of its potential returns per unit of risk. FactSet Research Systems is currently generating about 0.19 per unit of risk. If you would invest 80,055 in Bristol Myers Squibb on September 2, 2024 and sell it today you would earn a total of 20,500 from holding Bristol Myers Squibb or generate 25.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.44% |
Values | Daily Returns |
Bristol Myers Squibb vs. FactSet Research Systems
Performance |
Timeline |
Bristol Myers Squibb |
FactSet Research Systems |
Bristol-Myers Squibb and FactSet Research Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol-Myers Squibb and FactSet Research
The main advantage of trading using opposite Bristol-Myers Squibb and FactSet Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, FactSet Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FactSet Research will offset losses from the drop in FactSet Research's long position.Bristol-Myers Squibb vs. Novartis AG | Bristol-Myers Squibb vs. Bayer AG | Bristol-Myers Squibb vs. Astellas Pharma | Bristol-Myers Squibb vs. Roche Holding AG |
FactSet Research vs. Dun Bradstreet Holdings | FactSet Research vs. Moodys | FactSet Research vs. MSCI Inc | FactSet Research vs. Intercontinental Exchange |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |